Different ventilation intensities among various categories of patients ventilated for reasons other than ARDS--A pooled analysis of 4 observational studies

J Crit Care. 2024 Jun:81:154531. doi: 10.1016/j.jcrc.2024.154531. Epub 2024 Feb 10.

Abstract

Purpose: We investigated driving pressure (ΔP) and mechanical power (MP) and associations with clinical outcomes in critically ill patients ventilated for reasons other than ARDS.

Materials and methods: Individual patient data analysis of a pooled database that included patients from four observational studies of ventilation. ΔP and MP were compared among invasively ventilated non-ARDS patients with sepsis, with pneumonia, and not having sepsis or pneumonia. The primary endpoint was ΔP; secondary endpoints included MP, ICU mortality and length of stay, and duration of ventilation.

Results: This analysis included 372 (11%) sepsis patients, 944 (28%) pneumonia patients, and 2040 (61%) patients ventilated for any other reason. On day 1, median ΔP was higher in sepsis (14 [11-18] cmH2O) and pneumonia patients (14 [11-18]cmH2O), as compared to patients not having sepsis or pneumonia (13 [10-16] cmH2O) (P < 0.001). Median MP was also higher in sepsis and pneumonia patients. ΔP, as opposed to MP, was associated with ICU mortality in sepsis and pneumonia patients.

Conclusions: The intensity of ventilation differed between patients with sepsis or pneumonia and patients receiving ventilation for any other reason; ΔP was associated with higher mortality in sepsis and pneumonia patients.

Registration: This post hoc analysis was not registered; the individual studies that were merged into the used database were registered at clinicaltrials.gov: NCT01268410 (ERICC), NCT02010073 (LUNG SAFE), NCT01868321 (PRoVENT), and NCT03188770 (PRoVENT-iMiC).

Keywords: Critical care; Driving pressure; Mechanical power; Pneumonia; Ventilation intensity; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Intensive Care Units
  • Lung
  • Pneumonia*
  • Respiration, Artificial / adverse effects
  • Respiratory Distress Syndrome* / etiology
  • Respiratory Distress Syndrome* / therapy
  • Sepsis* / etiology
  • Sepsis* / therapy

Associated data

  • ClinicalTrials.gov/NCT03188770
  • ClinicalTrials.gov/NCT02010073
  • ClinicalTrials.gov/NCT01868321
  • ClinicalTrials.gov/NCT01268410